南非耐利福平结核口服9个月方案的治疗依从性
前瞻性观察队列研究在南非转诊结核医院纳入248例≥15岁肺结核RR-TB患者,使用数字药盒和直接观察治疗测量依从性。总体中位依从性82%(IQR 63%-98%),识别出四种依从轨迹,其中23.0%和12.0%的患者分别在3个月和6个月时依从性下降50%。
要点
- 口服9-12个月RR-TB方案总体中位依从性82%,数字药盒单测为72%。
- 依从性随时间下降呈四种轨迹,23.0%在3个月、12.0%在6个月降50%。
- 独立门诊治疗、仅用短程方案和年龄<40岁与依从性下降相关。
核心结论
- RR-TB口服方案治疗依从性随时间下降,呈现四种不同轨迹。
- 轨迹分组特征可识别需要强化治疗支持的患者。
研究设计与样本
- 前瞻性观察队列研究,在南非转诊结核医院开展。
- 纳入248例≥15岁肺结核RR-TB患者,开始口服9-12个月方案。
- 209例(84.3%)有可评估的依从性数据。
- 采用数字药盒(门诊)和直接观察治疗(住院)测量依从性。
- 使用潜类别组基轨迹模型识别依从模式。
主要发现
- 总体中位依从性82%(IQR 63%-98%,联合测量),数字药盒单测72%(IQR 51%-92%)。
- 第一个月依从性为93%-100%。
- 两组共136例(65.1%)依从性小幅下降,早期依从性高低不同。
- 另两组分别在3个月(48/209,23.0%)和6个月(25/209,12.0%)依从性下降50%。
- 依从性下降与独立门诊治疗、仅用短程方案、年龄<40岁相关。
临床怎么用
- 对独立门诊治疗、仅用短程方案及年龄<40岁的RR-TB患者应加强治疗支持。
- 可利用早期依从性轨迹识别后续依从性下降高风险者。
局限性
- 单中心转诊医院研究,结果外推需谨慎。
- 仅209/248例(84.3%)有可评估依从性数据。
- 数字药盒与直接观察治疗两种测量方式可能影响依从性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adherence to anti-tuberculosis (TB) therapy is an important determinant of treatment outcome in rifampicin-resistant tuberculosis (RR-TB). Understanding adherence to contemporary treatment regimens in routine care is needed to support implementation in TB programs. We aimed to characterize temporal adherence patterns among people receiving oral treatment for RR-TB. METHODS: We conducted a prospective observational cohort study at a referral TB hospital in South Africa. People aged ≥15 years with pulmonary RR-TB starting an oral 9- to 12-month regimen were included. Treatment adherence was measured using a digital pillbox during ambulatory care and with directly observed therapy during hospital care. The primary outcome was proportion of adherence days through 9 months. Latent class group-based trajectory modeling was used to identify temporal adherence patterns. RESULTS: Of 248 participants, 209 (84.3%) had assessable adherence data from the digital pillbox or directly observed therapy. Overall median adherence was 82% (interquartile range [IQR], 63%-98%) with combined measures, and 72% (IQR, 51%-92%) with digital pillbox only. Four distinct adherence patterns were identified. Adherence was 93%-100% in the first month. Two groups, representing 136 (65.1%) individuals, had small reductions in adherence over time, separated by higher and lower early adherence. In the other 2 groups, there was a 50% reduction in adherence by month 3 (48/209 [23.0%]) and month 6 (25/209 [12.0%]), respectively. Lower adherence over time was associated with having exclusive ambulatory care, treatment with the shorter regimen only, and age <40 years. CONCLUSIONS: Treatment adherence declined over time in distinct temporal patterns. Group characteristics could identify individuals who may benefit from enhanced treatment support.
引用
- Kuhlin J, Stadler JAM, Grint DJ, et al. Treatment Adherence With an Oral 9-Month Regimen for Rifampicin-Resistant Tuberculosis in South Africa. Clin Infect Dis. 2026. PMID: 41664844. doi:10.1093/cid/ciag069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。